Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Phibro Animal Health (PAHC)

Phibro Animal Health: Director Joyce J. Lee to resign from board effective April 15, 2026

Neutral Impact 2 of 5 leadership Written later

Phibro Animal Health director Joyce J. Lee informed the company on April 13, 2026 that she intends to resign from the Board effective April 15, 2026. The filing states her resignation was not due to any disagreement with the company on its operations, policies or practices.

Key points

  • Joyce J. Lee, a Class II Director, intends to resign effective April 15, 2026
  • Notice was given to the company on April 13, 2026
  • Filing states no disagreement with the company on operations, policies or practices

The filing

CompanyPhibro Animal Health (PAHC)
Form8-K, current report
Filed with the SECApr 14, 2026, 4:15 PM ET
Accession number0001104659-26-043188

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 14, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.